Neurenati Therapeutics jobs and careers
As of October 24, 2026, Neurenati Therapeutics has no open roles listed.
About Neurenati Therapeutics
Neurenati develops novel therapies for GI rare diseases
Founded in 2020 by Nicolas Pilon and Rodolphe Soret.
- Founded
- 2020
- Employees
- 1 to 10
- Total funding
- $2.6M
Leadership
The top of Neurenati Therapeutics's org chart, with how many people report into each leader.
MR
Maxime Ranger
Chief Executive Officer
4 reports
NP
Nicolas Pilon
Chief Scientific Officer
1 report
MK
Meriam Kabbaj
Chief Development Officer (CDO)
CM
Christophe Mellon
Vice-president CMC
Jobs at Neurenati Therapeutics
No open positions right now. Explore more companies on TheJobsMap.
Neurenati Therapeutics jobs: common questions
- Is Neurenati Therapeutics hiring right now?
- Neurenati Therapeutics has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Neurenati Therapeutics's careers site.
- Who leads Neurenati Therapeutics?
- Maxime Ranger, Chief Executive Officer, is at the top of Neurenati Therapeutics's org chart.
- How do I apply for a job at Neurenati Therapeutics?
- Pick a role on Neurenati Therapeutics's TheJobsMap page and select Apply. Every listing links to the original posting on Neurenati Therapeutics's own careers site, so you apply directly with the employer.